CorMedix Inc.
NASDAQ: CRMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph Todisco
- Employees
- 64
- Headquarters
- Berkeley Heights, United States
- IPO year
- 2010
- Market cap
- $658.2M
- Website
- https://www.cormedix.com
Loading CRMD…
Loading profile data…Frequently asked questions about CRMD
What does CorMedix Inc. (CRMD) do?
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. T...
Where does CRMD trade?
CorMedix Inc. (CRMD) trades on the NASDAQ Global Market.
What sector is CRMD in?
CorMedix Inc. (CRMD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CorMedix Inc.?
Joseph Todisco is the chief executive officer of CorMedix Inc. (CRMD).
Where is CorMedix Inc. headquartered?
CorMedix Inc. is headquartered in United States.
Does CRMD pay a dividend?
CorMedix Inc. (CRMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRMD go public?
CorMedix Inc. (CRMD) completed its initial public offering in 2010.